发明名称 Substituted pyrazino[1,2-a]pyrimidines useful as CBP/catenin antagonists for enhancing asymmetric division of somatic stem cells
摘要 Provided are: composition and methods for: treating aging or an age-related condition, symptom or disease; stimulating hair growth, regrowth or pigmentation (or preventing hair loss); for increasing adenosine receptor expression in dermal cells (in combination with hair growth); for treating a condition or disease of the skin or at least one symptom thereof, including cosmetic treatment (e.g., wrinkles, hyperpigmentation, redness, rosacea, dryness, cracking, loss of firmness, loss of elasticity, thinning, and loss of vibrancy). The methods comprise administering a sufficient amount of the disclosed CBP/catenin (e.g., CBP/(β-catenin) antagonist compositions, and particularly wherein administration is in an amount and manner sufficient to provide for increasing the number of asymmetric renewing divisions relative to, or at the expense of symmetric divisions in relevant somatic stem cell population. In particular aspects, the CBP/catenin (e.g., CBP/(β-catenin) antagonist comprises an alkyl and/or fatty acid ester derivative of formula (I) as disclosed herein;
申请公布号 US9371330(B2) 申请公布日期 2016.06.21
申请号 US201214350342 申请日期 2012.05.15
申请人 University of Southern California 发明人 Kahn Michael;Teo Jia-Ling;McMillan Michael;Zhao Yi;Wu Yongfeng
分类号 A61K31/4985;C07D241/38;C07D487/04 主分类号 A61K31/4985
代理机构 Davis Wright Tremaine LLP 代理人 Davison Barry L.;Davis Wright Tremaine LLP
主权项 1. A compound having the formula (I): wherein R1 is selected from hydrogen or C1-C6 alkyl, and wherein R2 is selected from —OH or —O(CO)(CH2)nCH3, wherein n is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, or 34, and provided that where R1 is hydrogen, R2 cannot be —OH; or a pharmaceutically acceptable salt thereof.
地址 Los Angeles CA US
您可能感兴趣的专利